| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/25/2013 | CN102525998B Preparation process of glutamine enteric microcapsules |
| 12/25/2013 | CN102512391B Azelnidipine quick-releasing drug preparation and preparation method |
| 12/25/2013 | CN102504006B Steroid saponin compound in siberian fritillary bulb |
| 12/25/2013 | CN102497855B Multi-layered gradient vaginal ring |
| 12/25/2013 | CN102492006B Canthaxanthin compound and application of compound to preparation of antitumor drugs |
| 12/25/2013 | CN102488767B Compound composition for treating bacterial diarrhoea of livestock and poultry |
| 12/25/2013 | CN102485241B Traditional Chinese medicine composition having functions of dispelling wind, clearing heat, removing toxins and benefiting throat and preparation method thereof |
| 12/25/2013 | CN102481279B Topical parasiticide composition |
| 12/25/2013 | CN102475830B Medicinal composition for treating coronary disease and angina pectoris, preparation method thereof and preparation thereof |
| 12/25/2013 | CN102470136B PLK inhibitor salts |
| 12/25/2013 | CN102382154B Saponin compound, preparation method for same, and application thereof in immunologic adjuvant preparation |
| 12/25/2013 | CN102382085B Benzofuran phenylpropanoids compound, preparation method and application thereof |
| 12/25/2013 | CN102344351B Aryl-substituted chalcones compound, its preparation method and its application |
| 12/25/2013 | CN102293819B Tea saponin vagina-protecting lotion |
| 12/25/2013 | CN102285993B Tetrahydropyridine oxapicene derivative as well as preparation method and application thereof |
| 12/25/2013 | CN102272120B Biologically active amides |
| 12/25/2013 | CN102250170B Preparation method and application of two active flavonoid glycosides in okra fruits |
| 12/25/2013 | CN102249975B (S)-4-hydroxy-2-oxo-1-pyrrolidineacetamide crystal form I and preparation method and application thereof |
| 12/25/2013 | CN102234336B Fucoidan-galactosan sulfate, extracting, separating, and purifying method thereof, and application thereof |
| 12/25/2013 | CN102212014B Crystal form of O-demethyl-venlafaxine glutamate, preparation method and medicinal application thereof |
| 12/25/2013 | CN102174046B Tetomilast polymorphs |
| 12/25/2013 | CN102171183B Organic compounds |
| 12/25/2013 | CN102164920B Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof as FAAH enzyme inhibitor |
| 12/25/2013 | CN102149376B Long-term treatment of symptomatic heart failure |
| 12/25/2013 | CN102146076B Anilinoquinazoline derivatives and preparation method thereof |
| 12/25/2013 | CN102143953B Pyrimidines, triazines and their use as pharmaceutical agents |
| 12/25/2013 | CN102100739B Traditional Chinese medicine composition containing salvianic acid A and pseudoginseng root saponin R1 and application thereof |
| 12/25/2013 | CN102091345B Sodium alga acid composition and application thereof |
| 12/25/2013 | CN102085209B Medicinal composition for treating senile dementia |
| 12/25/2013 | CN102085208B Pharmaceutical composition for treating coronary heart disease and angina |
| 12/25/2013 | CN102085194B Levetiracetam oral disintegrating tablet and preparation method thereof |
| 12/25/2013 | CN102058872B Medicinal composition containing Lysinopril and amlodipine besilate and preparation method thereof |
| 12/25/2013 | CN102049048B Method of treatment or prophylaxis |
| 12/25/2013 | CN102046596B Substituted cyclohexyldiamines |
| 12/25/2013 | CN102028754B Method for rapidly preparing total lignans and total saponins from schisandra chinensis |
| 12/25/2013 | CN102020602B Crystal form of lercanidipine hydrochloride and preparation method thereof and crystal form-containing medicinal composition |
| 12/25/2013 | CN102015702B Cyclic ethers |
| 12/25/2013 | CN101969949B MMP-2 and/or MMP-9 inhibitor |
| 12/25/2013 | CN101935306B Diketone piperazidine-like derivative and application thereof |
| 12/25/2013 | CN101868465B Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith |
| 12/25/2013 | CN101835737B Spiro-ring compound and use thereof for medical purposes |
| 12/25/2013 | CN101754962B N-azacyclic substituted pyrrole, imidazole, triazole and tetrazole derivatives as agonists of RUP3 or GPR119 for treatment of diabetes and metabolic disorders |
| 12/25/2013 | CN101747258B N-[(3aR, 4R, 4aR, 5aS, 6S, 6aS)-1,3-dioxo-3, 3a, 4, 4a 5, 5a, 6, 6a-octa-4,6- ethenylene cyclopropane[f] Isoindoline-2(1H)-base]-4-(trifluoromethyl) benzamide-hydrate and medical purpose thereof |
| 12/25/2013 | CN101732258B Nano microsphere preparation used for chemotherapy of tumors and preparation method thereof |
| 12/25/2013 | CN101679430B 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of ORL-i receptor for treatment of anxiety and depression |
| 12/25/2013 | CN101648002B Medicinal composition for treating skin injury and ulcer and application thereof |
| 12/25/2013 | CN101432277B Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 12/25/2013 | CN101129382B Antibiotic compound containing beta-lactam antibiotic and buffering component |
| 12/25/2013 | CN101100466B Non-reversible protein tyrosine phosphorus acylase inhibitor and its preparation and application |
| 12/24/2013 | US8614330 Substituted benz-azoles and methods of their use as inhibitors of RAF kinase |
| 12/24/2013 | US8614329 Polymorphs of sorafenib acid addition salts |
| 12/24/2013 | US8614328 4′-O-substituted isoindoline derivatives and compositions comprising and methods of using the same |
| 12/24/2013 | US8614327 Modulators of ATP-binding cassette transporters |
| 12/24/2013 | US8614320 Preparation of aminopyrimidine compounds |
| 12/24/2013 | US8614313 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 12/24/2013 | US8614291 Phosphorylated polymers and conjugates thereof |
| 12/24/2013 | US8614285 Photosensitizer based on polymer derivatives-photosensitizer conjugates for photodynamic therapy |
| 12/24/2013 | US8614254 Methods and compositions for treating thalamocortical dysrhythmia |
| 12/24/2013 | US8614253 IRE-1α inhibitors |
| 12/24/2013 | US8614252 Crystalline solid rasagiline base |
| 12/24/2013 | US8614251 Crystalline form VI of agomelatine, preparation method and application thereof |
| 12/24/2013 | US8614250 Uses of adipic acid |
| 12/24/2013 | US8614249 Medicaments containing pantothenic acid |
| 12/24/2013 | US8614248 Use of esters of long-chain fatty acids for treatment of autoimmune diseases |
| 12/24/2013 | US8614247 Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof |
| 12/24/2013 | US8614246 Indole derivatives for treating neurodegenerative diseases |
| 12/24/2013 | US8614245 Crystalline (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine |
| 12/24/2013 | US8614244 Spot-on pesticide composition |
| 12/24/2013 | US8614243 Small-molecule modulators of Trp-p8 activity |
| 12/24/2013 | US8614242 1-(heterocyclic carbonyl)-2-substituted pyrrolidines |
| 12/24/2013 | US8614241 Ester compound and use thereof |
| 12/24/2013 | US8614240 Benzoxazole derivatives having inhibitory activity against interleukin-6, preparation method thereof, and pharmaceutical composition containing the same |
| 12/24/2013 | US8614239 Heterocyclic sulfonamide derivatives |
| 12/24/2013 | US8614238 Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
| 12/24/2013 | US8614237 Benzofuran-4,5-diones as selective peptide deformylase inhibitors |
| 12/24/2013 | US8614236 Methods of treating pulmonary disease using acetazolamide and structurally related derivatives |
| 12/24/2013 | US8614235 CAI-based systems and methods for the localized treatment of ocular and other diseases |
| 12/24/2013 | US8614234 Compounds as tyrosine kinase modulators |
| 12/24/2013 | US8614233 Cinnamoyl inhibitors of transglutaminase |
| 12/24/2013 | US8614232 Injectable depot formulation comprising crystals of iloperidone |
| 12/24/2013 | US8614231 Immunosuppressor based on the blockage of TCR-Nck interaction |
| 12/24/2013 | US8614230 Derivatives of the aminated hydroxyquinoline class for treating cancers |
| 12/24/2013 | US8614229 Substituted indole derivatives and methods of use thereof |
| 12/24/2013 | US8614228 Quinone prodrug compositions and methods of use |
| 12/24/2013 | US8614227 Salt and solvates of a tetrahydroisoquinoline derivative |
| 12/24/2013 | US8614226 Hetaryl-[1,8]naphthyridine derivatives |
| 12/24/2013 | US8614225 Process for the purification of palonosetron or its salt |
| 12/24/2013 | US8614224 Sinomenine derivatives and processes for their synthesis |
| 12/24/2013 | US8614223 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof |
| 12/24/2013 | US8614222 Methods of preventing and treating low bone mass diseases |
| 12/24/2013 | US8614221 Inhibitors of Akt activity |
| 12/24/2013 | US8614220 Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors |
| 12/24/2013 | US8614219 Substituted pyrimidin-4-one derivatives |
| 12/24/2013 | US8614218 Fused bicyclic pyrimidines |
| 12/24/2013 | US8614216 Crystalline and other forms of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salts |
| 12/24/2013 | US8614215 Quinoxaline inhibitors of phosphoinositide-3-kinases (PI3Ks) |
| 12/24/2013 | US8614214 Pyrazole amide compounds and uses thereof |
| 12/24/2013 | US8614213 Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists |
| 12/24/2013 | US8614212 Anxiolytic compounds |
| 12/24/2013 | US8614211 Certain chemical entities, compositions, and methods |